Healthcare Blogs and Articles
Healthcare Blogs and Articles
Healthcare Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Cera, Europe’s leading digital‑first home‑healthcare provider, announced it has surpassed 300 billion data points collected from more than 2.5 million patient visits each month. The dataset records symptoms, mobility changes, medication responses, nutrition, mood and behavioural signals, creating one of the world’s most comprehensive real‑world health records outside clinical settings. Cera is using this trove to power AI agents, predictive analytics and robotics while offering anonymised insights to pharmaceutical and life‑science partners for research on dementia, neurological and chronic diseases. The milestone underpins Cera’s strategy to accelerate AI‑driven care, improve outcomes and support drug development.
Shared Care Records (SCRs) have progressed from simple document‑exchange portals to intelligent, conversational platforms that actively assist clinicians and patients. The first generation provided read‑only visibility, while the second introduced structured, longitudinal data enabling real‑time contributions. A third phase turned...
Dr Haus Dermatology has introduced a consultant‑led medical weight‑management service, headed by endocrinologist Dr Edson Nogueira. Initial consultations occur in person at its Harley Street clinic, with optional video follow‑ups and home delivery of prescribed treatments. The integrated pathway combines...
Physicians practicing across state lines face a fragmented landscape of continuing medical education (CME) mandates, with requirements ranging from zero hours in Montana to 200 hours in Washington over four years. License renewal deadlines also differ widely, tied to birthdays,...
Eurofins Biomnis has developed and validated a new LC‑MS/MS method to detect and quantify cereulide toxin in human stool samples. The assay meets ISO 15189 requirements, accounting for matrix effects, and delivers turnaround times suitable for routine clinical labs. Cereulide, linked...
The FDA granted its first approval for a therapy targeting cerebral folate transport deficiency, an ultra‑rare neurological disorder, with Wellcovorin (leucovorin calcium) showing meaningful neurological improvements in 89% of patients. Meanwhile, over‑the‑counter naloxone prices have slipped by roughly $0.49 each...
Homeland Security Investigations raided Bright Future Healthier You, a Somali‑owned behavioral health firm in Lewiston, after a federal probe uncovered a multi‑million‑dollar Medicaid interpreter fraud and tax scheme. The company billed MaineCare for interpretation services, receiving about $15.58 million between 2019...
Health Tech World Awards 2026 will honor innovators across life sciences, medtech, and digital health, with a dedicated AI Innovation award recognizing breakthroughs that improve diagnosis, treatment, and research. Sponsored by international law firm Osborne Clarke, the award highlights AI applications...
DexCom will unveil new real‑world evidence at ATTD 2026 showing its CGM improves HbA1c in non‑insulin‑treated Type 2 patients, reduces DKA‑related hospitalizations in Type 1 patients, and supports a safe Smart Basal insulin‑optimization system. The company also detailed a product roadmap featuring...
Out‑Of‑Pocket’s 2025 outlook forecasts a turning point for several health‑care segments. Obesity drugs such as GLP‑1s are expected to become cost‑effective as pricing pressure and outcomes‑based contracts expand access. AI models will split, with healthcare‑specific versions emphasizing explainability, security and...
Digital‑health founders struggle with traditional venture financing, prompting a proposed three‑stage fund that blends early equity with royalty‑based repayment to limit dilution. The author suggests 23andMe should merge with or create a biobank to leverage its high‑participation genetic data for...
The sleep health market is merging consumer wearables with clinical diagnostics, creating a surge in demand for at‑home screening and management tools. New devices—from Oura rings to at‑home apnea kits—provide continuous biomarkers that flag issues before formal polysomnography. Telemedicine platforms...
The post announces three upcoming healthcare courses—payor contracting, LLM applications, and a US healthcare crash course—each with limited enrollment beginning in December and January. It critiques the stagnant fraud‑waste‑abuse detection market, citing data access barriers and weak incentives, and proposes...
The article explains three emerging health‑insurance tactics—intercompany eliminations, copay accumulators/maximizers, and reference‑based pricing—that reshape cost flows and patient liabilities. Intercompany eliminations let insurers count payments to owned providers toward medical loss‑ratio requirements, effectively boosting margins. Copay accumulators prevent manufacturer coupons...
The Newcastle upon Tyne Hospitals NHS Trust partnered with Solventum to co‑design an AI‑enabled Follow‑Up Finder tool that screens radiology reports for venous thromboembolism (VTE). By embedding the solution in the electronic patient record, the system achieved over 99.9% sensitivity...
Urinary incontinence affects more than one‑third of women over 40 and up to half of post‑menopausal women, while men see higher rates after prostate surgery. The blog outlines a 12‑week biohacking plan that blends functional pelvic‑floor exercises, targeted nutrition, evidence‑based...
![Understanding the Science Behind Embryo Grading Improves IVF Decision Making [PODCAST]](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://kevinmd.com/wp-content/uploads/Design-1-scaled.jpg)
In a KevinMD podcast, reproductive endocrinologist Dr. Erica Bove breaks down embryo grading, contrasting day‑three cell counts with day‑five blastocyst morphology. She explains how labs assess cell number, fragmentation, trophectoderm and inner cell mass to assign grades such as 8A...
The article coins the term “unfinishedness” to describe medical visits that are clinically appropriate yet leave patients feeling unresolved. It explains how clinicians often close encounters administratively without sharing the reasoning behind uncertainty, creating a gap between technical success and...
The FDA has expanded approval of leucovorin calcium tablets as the first therapy for cerebral folate transport deficiency linked to FOLR1 gene variants. The decision relied on published case literature, showing 87‑89% of patients achieved clinical improvement. In oncology, AstraZeneca...
Day one of HIMSS 2026 highlighted a growing momentum in health‑tech interoperability, with real‑world data exchanges like Clover Health’s CMS network monitor demonstration. The conference underscored pharmacists’ untapped potential as data‑rich care partners, yet noted fragmented systems limit their impact....
Researchers at Friedrich‑Alexander‑Universität Erlangen‑Nürnberg successfully vitrified mouse brain slices and, in a limited trial, an entire mouse brain, preserving neuronal structure and function after rewarming. By using a high‑concentration cryoprotective agent cocktail, they avoided ice crystal formation, maintained synaptic architecture,...
A recent Health and Retirement Study analysis shows that women who have entered menopause are about 24 percent less likely to receive a Pap smear within four years compared with pre‑menopausal peers. This decline coincides with the average cervical‑cancer diagnosis age...
The Texas Attorney General filed an opposition to Epic’s motion to dismiss, arguing that Epic cannot import federal summary‑judgment standards into a state‑court pleading under Texas Rule 91a. The brief emphasizes that Epic’s reliance on a patchwork of federal cases...
Nurix Therapeutics has launched NX-1607, the first orally bioavailable small‑molecule inhibitor of the immune regulator CBL‑B, into a Phase 1a/1b trial for advanced cancers. CBL‑B modulates activation of T, B and NK cells, and NX-1607 locks the protein in an inactive...
A bipartisan call in Washington urges the United States to make curing Alzheimer’s a flagship scientific enterprise. The proposal calls for billions in basic brain research, Medicare coverage for early diagnosis and preventive treatment starting at age 50, and parity...
Deaminet 2026 showcased accelerating advances in base and prime editing, highlighted by rapid Addgene distribution growth and new mechanistic insights such as PE6d’s heightened processivity and ABE8e’s dimer‑driven efficiency. Novel off‑target detection platforms like beCasKAS and Inrich‑seq revealed far more unintended...
The Nottingham City Place‑Based Partnership is rolling out neighbourhood‑focused preventive health services to align with the NHS 10‑Year Plan. By deploying free SISU Health Stations in community hubs such as a deprived suburb, a Boots store and a football fan...
Sam Shainberg’s short film “Endless Sea” follows Carol, a flower‑delivery worker, as she scrambles to pay a $365 co‑pay for life‑saving heart medication, exposing the harsh reality of tiered prescription pricing. Set on a rainy Valentine’s Day, the 17‑minute thriller...
Cardiac amyloidosis affects up to a quarter of people over 80 yet remains largely undiagnosed. Characteristic echocardiographic signs—including thickened walls, restrictive filling patterns, and the apical‑sparing strain signature—allow clinicians to suspect the disease early. Differentiating the three amyloid subtypes on...
The Femtech Company of the Year award, sponsored by Cross‑Border Impact Ventures (CBIV), seeks to elevate firms that are reshaping women’s health through technology. It recognizes companies tackling reproductive health, maternal care, menopause and related gaps, rewarding exceptional impact and...
French biotech Ipsen announced an immediate, global voluntary withdrawal of its oncology drug tazemetostat (Tazverik) after safety signals in the SYMPHONY‑1 confirmatory trial indicated a rise in secondary hematologic malignancies. The company is coordinating with the FDA to manage the...
The blog post contends that puberty‑blocking drugs such as Lupron cause irreversible damage, highlighting a social‑media case of jaw deterioration and enamel loss. It asserts that these medications lead to permanent bone mineral density loss and lifelong health risks, framing...
The UK Department of Health and Social Care has answered its five‑week consultation on NICE regulations by granting ministers a limited power to set the cost‑effectiveness threshold used in technology appraisal (TA) and highly specialised technology (HST) programmes. The change...
The FDA has eliminated the longstanding requirement for two pivotal clinical trials, adopting a single‑trial default to speed drug approvals. The agency pairs this change with a mandate for more rigorous post‑market surveillance to catch safety signals after launch. Pharmaceutical...
Researchers at Texas Children’s Duncan Neurological Research Institute and Baylor College of Medicine demonstrated that skipping exon e2 of the MECP2 gene boosts MeCP2 protein production by 50‑60%, rescuing neuronal function in Rett syndrome mouse models and patient‑derived cells. The study...
Amid rising mental‑health crises, policy attacks, and AI‑driven discourse, author Mike Magee argues that a liberal‑arts education offers a vital counterbalance to the divisive Trump era. He highlights how institutions like Le Moyne College embed ethics, history, and critical thinking into...
David Creel, PhD, RD, a clinical psychologist and dietitian at the Cleveland Clinic, emphasizes that lasting weight‑loss hinges on behavioral psychology rather than isolated diet or exercise prescriptions. He outlines a framework that blends collaborative communication, self‑monitoring, skill‑building, and relapse‑prevention...
The article highlights e‑prescribing’s rapid national rollout, which eliminated paper scripts and enabled direct provider‑to‑pharmacy transmission. However, critical gaps remain: pharmacies cannot share real‑time inventory data, and pharmacy‑to‑pharmacy transfers still rely on fax and phone calls. The author’s personal experience—an...
Shield Therapeutics announced that the FDA has approved Accrufer, its ferric maltol oral iron formulation, for children ages 10 and older, making it the first prescription oral iron therapy for this age group. The approval expands the drug’s label beyond...
The latest #CareTalk episode highlights how decades of chronic underfunding have left America’s public health infrastructure fragile. Dr. Stella Safo of Civic Health Alliance warns that essential health‑security institutions are being dismantled and calls on the healthcare sector to defend...
Conversational AI tools such as ChatGPT Health and Claude for Healthcare are reshaping how patients and clinicians obtain medical information. OpenAI reports that over 5% of global ChatGPT interactions—about 40 million daily users—are health‑related, while 40% of U.S. healthcare workers use...
Vinay Prasad has left the FDA’s Center for Biologics Evaluation and Research (CBER) for the second time in under a year, signaling a notable leadership turnover at a key regulatory hub for biologics, vaccines and gene therapies. In parallel, GlaxoSmithKline...
Physician wellness leaders are confronting a hidden paradox: while therapy is increasingly normalized, medication use remains stigmatized. Psychiatrist Jessi Gold, chief wellness officer for the University of Tennessee System, disclosed her 13‑year daily Wellbutrin regimen, revealing the pressure physicians feel...
Taisho Pharmaceutical’s vornorexant (TS‑142), marketed as Vorzzz®, received Japanese regulatory approval in August 2025 as a dual orexin‑1/2 receptor antagonist for insomnia. The drug distinguishes itself from existing DORAs through rapid absorption and a short elimination half‑life, aiming to minimize...
The traditional fully in‑person outpatient physical‑therapy model is under strain from tighter reimbursement, staffing shortages, and patients demanding more flexible scheduling. Clinics are turning to hybrid care, combining essential hands‑on visits with short virtual check‑ins to maintain outcomes while improving...
Developmental‑behavioral pediatrician Ronald L. Lindsay reflects on a 1998 grant that outlined nine concrete goals to address health disparities for children with neurodevelopmental disabilities, women with disabilities, and underserved families. He argues that his early warnings—now framed as a Cassandra‑type...
The National Community Pharmacists Association (NCPA) warns that independent pharmacies are facing a cash‑flow crisis as 67% report Medicare drug‑price negotiation refunds delayed 22 days or more, forcing 60% to dip into personal savings. NCPA is urging the Centers for...
The ACA’s state‑run health‑insurance marketplaces, which require essential benefits and sort plans into Platinum, Gold, Silver and Bronze tiers, covered about 10 million people before COVID‑19. A 2021 expansion of premium tax credits more than doubled enrollment to 23 million and pushed...
Veterans Affairs’ homegrown VistA electronic health record, praised for usability and clinical outcomes, was replaced by Cerner’s commercial Millennium platform through a sole‑source $10 billion contract. The transition has ballooned to an estimated $37‑$50 billion, far exceeding the roughly $2 billion that modernizing...
Bausch + Lomb announced the kickoff of an R&D “Teach‑in” webinar series, beginning with a March 23 session focused on its glaucoma pipeline. Executive Vice President of R&D Yehia Hashad and senior leaders will discuss ELios™, an implant‑free laser glaucoma surgery already launched in...
